Search

everythinglearnresearchcommunity

for

Search:↓

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

A new gene mutation causes insulin resistance in a girl and her mother.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

Aromatase gene variation may increase female hair loss risk.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Eating a high-glycemic diet may worsen acne by increasing certain protein levels and expressions in the skin.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Hsc70 protein may influence hair growth by responding to androgens.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

The mouse models are effective for testing new hair loss treatments.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Treatment during development affects hormone balance and sexual behavior in male rats.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.